We serve Chemical Name:3-Chloropyridine CAS:626-60-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Chloropyridine
CAS.NO:626-60-8
Synonyms:3-Cl-pyridine;3-chloro-pyridine;MFCD00006375;EINECS 210-955-7;b-chloropyridine;m-Chloropyridine;Pyridine, 3-chloro-;3-Chloropyridine;Pyridine,3-chloro
Molecular Formula:C5H4ClN
Molecular Weight:113.545
HS Code:29333999
Physical and Chemical Properties:
Melting point:-0.5ºC
Boiling point:143.1±13.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.530
PSA:12.89000
Exact Mass:113.003227
LogP:1.57
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2822
Packing Group:III
Contact us for information like 3-Cl-pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyridine,3-chloro physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,m-Chloropyridine Use and application,3-chloro-pyridine technical grade,usp/ep/jp grade.
Related News: The company pinpointed Thousand Oaks for its expansion “based on capability, staffing as well as the local community and the things we could bring to the area,” Hatke, told the news outlet. 5,5-bis(phenylthio)pentan-2-one manufacturers For example, by using molecular modeling tools to achieve rapid de novo design of new enzymes, it may be possible to increase activity, enhance temperature stability, or improve solvent compatibility to better align with the process in question. 1-(2-methoxyphenyl)-3-(3-methylphenyl)propan-1-one suppliers Building on this progress, recombinant technologies have been key to optimizing the performance of biocatalytic reagents, for example by facilitating a reduction in the amount of enzyme needed to drive a reaction while at the same time increasing the yield. 5-(4-fluoro-3-methylphenyl)-5-oxopentanoic acid vendor & factory Lonza is investing CHF 20 million in GMP laboratories and mid-scale manufacturing assets at its API manufacturing center in Nansha, China. The investment will allow Lonza to provide a smoother transition from small-scale to large-scale manufacturing for customers.,According to Plexxikon, GSK scientists were only able to make Tafinlar after talks with Plexxikon about a potential partnership; although those talks never turned into a licensing deal, GSK apparently channeled that information and created a rival drug.
